Weighted Average Number of Shares Outstanding, Basic of CG Oncology, Inc. from Q1 2023 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CG Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2023 to Q3 2025.
  • CG Oncology, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 76.7M shares, a 14.3% increase year-over-year.
  • CG Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 62.5M shares, a 1343% increase from 2023.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

CG Oncology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 76.7M +9.59M +14.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 76.2M +9.58M +14.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 76.2M +29.1M +61.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 62.5M +58.2M +1343% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 67.1M +62.8M +1432% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 66.6M +62.7M +1601% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 47.1M +43.2M +1121% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 4.33M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 4.38M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 3.92M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 3.86M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09

CG Oncology, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 62.5M +58.2M +1343% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 4.33M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.